Wolfe Research analyst Mike Polark initiates coverage on Medtronic (NYSE:MDT) with a Underperform rating.
Shark Tank’s O’Leary Tussles With CNBC Over $11M Loss From FTX Fallout: Here’s What He Told Benzinga About His Next Move Involving An ‘Army Of Lawyers’
Renowned "Shark Tank" investor Kevin O'Leary is feeling the pain from the FTX fallout to the tune of $11 million and he's not willing to accept that the money made out like Harry Houdini and disappeared.
